Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Liabilities and Shareholders Equity (2024 - 2025)

Historic Liabilities and Shareholders Equity for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $105.6 million.

  • Pyxis Oncology's Liabilities and Shareholders Equity fell 4593.03% to $105.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $521.9 million, marking a year-over-year change of. This contributed to the annual value of $157.2 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Liabilities and Shareholders Equity is $105.6 million, which was down 4593.03% from $123.2 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Liabilities and Shareholders Equity registered a high of $220.2 million during Q1 2024, and its lowest value of $105.6 million during Q3 2025.